家禽诊断市场规模（按检测类型、疾病类型、服务、区域覆盖范围和预测）

家禽诊断市场规模及预测

2023 年家禽诊断市场规模价值为 5.6949 亿美元，预计到 2031 年将达到 13.0391 亿美元，2024 年至 2031 年的复合年增长率为 10.91%。家禽诊断是透过测试和分析家禽样整体诊断、监测和控制影响家禽族群的疾病和健康问题的过程。在该领域，您将使用各种实验室技术和诊断工具来识别导致鸡、火鸡、鸭和其他家禽疾病的感染、寄生虫和其他变数。家禽诊断对于维持家禽群的健康和生产、确保食品安全和保护动物福利至关重要。

这些诊断方法对于疾病监测、早期发现疫情以及实施有效的控制措施以防止传染病传播至关重要。

家禽诊断有助于维持家禽业的利润和永续发展，同时保护公众健康。

此外，家禽诊断可以帮助优化控制措施，如疫苗接种计划和生物安全协议，以降低疾病风险并促进永续家禽生产。

全球家禽诊断市场动态

影响家禽诊断市场的关键市场动态

主要市场驱动因子

家禽疾病流行：

禽流感和新城疫等家禽疾病在全球蔓延，对诊断的需求不断增加，以确保家禽健康、预防疾病爆发并减少经济损失。

增加家禽产量和消费量：

由于世界人口不断增长以及对高蛋白饮食的需求不断增加，家禽业正在不断扩大。随着家禽产量的增加，需要全面的疾病监测和控制技术来确保动物健康和食品安全。

诊断技术进步：

分子诊断、PCR（聚合酶链反应）和ELISA（酶联免疫吸附试验）等诊断技术的创新使得病原体识别速度更快、更准确、更灵敏，从而实现了鸡肉市场的先进疾病控制。这正在推动诊断方法的采用。

政府法规与动物福利：

政府对动物健康和食品安全的严格要求，加上人们对动物福利的认识不断提高，迫使家禽生产商使用诊断测试。这些规定将确保家禽产品安全食用且无疾病，从而促进市场成长。

主要问题

先进诊断技术的成本高：

对于中小型家禽养殖场来说，新型诊断方法和设备的高成本可能会限制其获得尖端诊断工具的机会，从而阻碍家禽疾病的早期诊断和控制。

生物安全与疾病控制：

儘管严格的生物安全和疾病控制措施难以实施，但对于避免传染病在家禽养殖场的引入和传播却是必要的。未能做到这一点会阻碍诊断，导致疾病爆发和经济损失。

发展中地区的认知与获取管道有限：

在许多发展中国家，人们对家禽疾病诊断的重要性知之甚少，由于缺乏诊断服务和设施，情况更加恶化。这种情况阻碍了有效的疾病检测和控制，并损害了家禽的整体健康。

熟练劳动力短缺：

由于缺乏能够操作先进诊断设备并正确解释数据的熟练劳动力，市场面临重大课题。这种不一致可能导致误诊和对疾病爆发的延迟反应，从而损害家禽的健康和农场的获利能力。

主要趋势：

整合分子诊断：

PCR 和次世代定序等分子诊断技术的整合因其快速、灵敏和特异的疾病检测能力而广受欢迎。这一趋势将加强疾病检测和控制措施，从而实现更好的家禽健康管理。

即时检定（POCT）：

适合现场使用的便携式、用户友好的诊断检测方法正在不断开发。 POCT能够实现家禽养殖场的疾病快速诊断和决策，减少实验室检测的时间和成本，同时有助于快速控制疫情。

自动化与数位化：

诊断过程自动化和结果数位化的趋势日益增长。自动化解决方案提高了诊断测试的吞吐量和统一性，而数位技术则实现了整个家禽市场的数据管理、趋势分析和资讯共享。

强调多因子疾病管理：

认识到疾病通常是由多种因素的复杂相互作用引起的，人们已经转向整体诊断，将遗传、环境和管理相关的疾病推动因素考虑在内。这项综合策略将促进更好的疾病预防和个人化治疗技术。

目录

第 1 章全球家禽诊断市场简介

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章。

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析
• 监理框架

5. 全球家禽诊断市场（依疾病类型）

• 概述
• 沙门氏菌病
• 禽流感
• 新城疫
• 禽支原体病
• 传染性支气管炎
• 传染性滑囊炎
• 禽巴氏桿菌病
• 禽脑脊髓炎
• 禽呼肠孤病毒
• 鸡贫血

6. 全球家禽诊断市场（按服务）

• 概述
• 病毒学
• 细菌学
• 寄生虫学

7. 全球家禽诊断市场（依测试类型）

• 概述
• 酵素连结免疫吸附试验（Elisa）测试
• 聚合酶连锁反应 (PCR) 检测
• 其他诊断测试

8. 全球家禽诊断市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 阿根廷
• 世界其他地区
  • 中东和非洲

第 9 章。

• 概述
• 公司市占率
• 供应商概况
• 主要发展策略

第十章 公司简介

• Idexx Laboratories, Inc.
• Zoetis, Inc.
• Thermo Fisher Scientific Inc.
• Qiagen N.V.
• GD Animal Health
• IDVet
• Affinitech, Ltd.
• Agrobiotek Internacional
• Biochek
• Bionote, Inc.
• Boehringer Ingelheim GmbH
• Bioingentech Biotechnologies, Inc.
• Megacor Diagnostik GmbH

第 11 章附录

• 相关报告

Poultry Diagnostics Market Size And Forecast

Poultry Diagnostics Market size was valued at USD 569.49 Million in 2023 and is projected to reach USD 1303.91 Million by 2031, growing at a CAGR of 10.91% from 2024 to 2031. Poultry diagnostics is the process of testing and analyzing poultry samples to diagnose, monitor, and control diseases and health issues that affect poultry populations. This discipline uses a variety of laboratory techniques and diagnostic tools to identify infections, parasites, and other variables that cause sickness in chickens, turkeys, ducks, and other poultry species. Poultry diagnostics are critical to maintaining the health and production of poultry flocks, assuring food safety, and protecting animal welfare.

These diagnostics are critical for disease surveillance, early detection of outbreaks, and the implementation of effective control measures to prevent the spread of infectious illnesses.

Poultry diagnostics help to maintain the profitability and sustainability of the poultry industry while also protecting public health.

Furthermore, poultry diagnostics help to optimize management measures such as vaccination programmes and biosecurity protocols, reducing disease risks and promoting sustainable poultry production.

Global Poultry Diagnostics Market Dynamics

The key market dynamics that are shaping the poultry diagnostics market include:

Key Market Drivers

Rising Prevalence of Poultry Diseases:

The global spread of poultry diseases such as avian influenza and Newcastle disease increases the demand for diagnostics to assure flock health, prevent disease outbreaks, and reduce economic losses, making timely and accurate diagnosis critical for effective disease management.

Expansion of Poultry Production and Consumption:

Poultry farming is expanding due to the growing global population and rising demand for protein-rich diets. Because of the increase in poultry production, comprehensive disease monitoring and control techniques are required to assure animal health and food safety.

Technological Advancements in Diagnostic Methods:

Diagnostic technology innovations such as molecular diagnostics, PCR (polymerase chain reaction), and ELISA (enzyme-linked immunosorbent assay) provide faster, more accurate, and sensitive pathogen identification, pushing the adoption of advanced diagnostics in the poultry market.

Government Regulations and Animal Welfare:

Stringent government requirements on animal health and food safety, combined with growing awareness of animal welfare, force poultry farmers to use diagnostic tests. These restrictions ensure that poultry products are safe to consume and disease-free, which promotes market growth.

Key Challenges:

High Costs of Advanced Diagnostic Technologies:

The high costs of new diagnostic methods and equipment are too expensive for small and medium-sized poultry farms, limiting their access to cutting-edge diagnostic tools and potentially impeding early diagnosis and control of poultry diseases.

Biosecurity and Disease Control Measures:

Strict biosecurity and disease control measures are difficult to implement but necessary to avoid the introduction and spread of infectious illnesses on poultry farms. Failures in these procedures hampered diagnostic attempts, resulting in extensive disease outbreaks and economic losses.

Limited Awareness and Access in Developing Regions:

In many underdeveloped countries, there is little knowledge of the relevance of poultry disease diagnostics, which is exacerbated by a lack of access to diagnostic services and facilities. This circumstance impedes effective disease detection and control, compromising overall poultry health.

Lack of Skilled Personnel:

The market faces a significant difficulty due to a dearth of skilled workers who can operate advanced diagnostic equipment and appropriately interpret data. This discrepancy causes misdiagnoses or delayed reactions to disease outbreaks, compromising poultry health and farm profitability.

Key Trends:

Integration of Molecular Diagnostics:

The integration of molecular diagnostics, such as PCR and next-generation sequencing, is gaining popularity due to its capacity to detect diseases quickly, sensitively, and specifically. This trend strengthens disease detection and control measures, resulting in better poultry health management.

Point-of-Care Testing (POCT):

The development of portable, user-friendly diagnostic assays for on-site use is gaining traction. POCT allows for quick disease diagnosis and decision-making on poultry farms, saving the time and cost of laboratory testing while also assisting in the rapid containment of epidemics.

Automation and Digitalization:

There is an increasing trend towards diagnostic process automation and result digitalization. Automated solutions improve diagnostic test throughput and uniformity, while digital technologies enable data administration, trend analysis, and information sharing across the poultry market.

Focus on Multifactorial Disease Management:

Recognizing that diseases are frequently caused by complex interactions of several factors, there is a shift towards comprehensive diagnostics that take into account genetic, environmental, and management-related disease triggers. This comprehensive strategy promotes better disease prevention and personalized treatment techniques.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Poultry Diagnostics Market Regional Analysis

Here is a more detailed regional analysis of the poultry diagnostics market:

North America:

According to Verified Market Research, North America is estimated to dominate during the forecast period. North America, particularly the United States, has some of the world's most modern poultry production technologies. This technological advantage enables early illness identification and management, resulting in the region's supremacy in the poultry diagnostics market.

The region has strong animal health regulations and standards that require regular health monitoring and illness testing in poultry farms. These laws increase demand for diagnostic testing, boosting the poultry diagnostics market in North America.

Animal health and food safety are widely understood among North American farmers and consumers. This knowledge, combined with major investment in animal health R&D, drives the use of modern diagnostic systems.

Furthermore, North America is home to several leading companies that specialize in animal health diagnostics. These companies are constantly innovating and expanding their product portfolios, contributing to the region's dominant position in the global poultry diagnostics market via their research skills and extensive distribution networks.

Europe:

Europe's severe food safety and animal welfare rules need regular health inspections and disease monitoring in poultry farming. This regulatory environment increases the requirement for diagnostic technologies to assure compliance and uphold high poultry health standards.

Europe is at the forefront of implementing modern diagnostic technologies such as molecular diagnostics and immunoassays. The availability and integration of these technologies into poultry health management techniques have a substantial impact on the regional poultry diagnostics market.

Furthermore, in Europe, there is a rising emphasis on preventative healthcare treatments for poultry to avert illness outbreaks. This preventive strategy has resulted in increased use of diagnostics to identify and control potential health risks before they spread.

Asia Pacific:

The Asia Pacific region's poultry market is rapidly expanding as a result of rising protein demand among its growing population. This expansion needs improved disease control procedures, increasing the demand for better poultry diagnostics solutions.

The Asia Pacific region is becoming more conscious of the importance of animal health and food safety. Governments and poultry producers are increasingly using diagnostic tools to safeguard the health and safety of poultry flocks and products.

Furthermore, the Asia Pacific market is experiencing the rise of local and regional enterprises that specialize in animal health diagnostics. These businesses are adapting their services to match the specific needs of the Asia Pacific market, hence enabling the adoption of poultry diagnostics solutions and adding to market growth.

Global Poultry Diagnostics Market: Segmentation Analysis

The Poultry Diagnostics Market is segmented based on Test Type, Disease Type, Service and Geography.

Poultry Diagnostics Market, Test Type

ELISA (Enzyme-Linked Immunosorbent Assay)

PCR (Polymerase Chain Reaction)

Others

Based on Test Type, the market is segmented into ELISA, PCR and Others. The PCR (Polymerase Chain Reaction) segment is estimated to dominate the poultry diagnostics market due to its unparalleled sensitivity and specificity, which allows for the detection of extremely low quantities of pathogen DNA or RNA in samples. This skill is especially useful for early disease detection, even before clinical indications arise, allowing for timely intervention and containment measures. Furthermore, the adaptability of the PCR technique enables the identification of a wide range of pathogens, including those causing emerging and re-emerging diseases, which is critical for maintaining biosecurity and disease control in poultry populations.

Poultry Diagnostics Market, By Disease Type

• Avian Salmonellosis
• Avian Influenza
• Newcastle Disease
• Infectious Bronchitis
• Infectious Bursal Disease
• Others

Based on Disease Type, the poultry diagnostics market is divided into Avian Salmonellosis, Avian Influenza, Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease and Others. The avian influenza segment is estimated to dominate the market over the forecast period due to Avian Influenza's widespread incidence and catastrophic impact on poultry populations worldwide. Avian influenza, sometimes known as bird flu, may quickly spread among birds and cause high mortality rates, resulting in severe economic losses for poultry farmers and the poultry industry as a whole. The disease is also a zoonotic issue, with the ability to spread from birds to humans, generating public health concerns. These considerations highlight the necessity for efficient, rapid diagnostic tools to detect and manage Avian Influenza outbreaks quickly.

Poultry Diagnostics Market, By Service

• Bacteriology
• Virology
• Parasitology

Based on Service, the poultry diagnostics market is divided into Bacteriology, Virology and Parasitology. The virology segment is estimated to grow at the highest CAGR over the forecast period owing to the widespread occurrence and economic effect of viral illnesses in poultry, such as avian influenza, Newcastle disease, and infectious bronchitis. These illnesses can cause serious outbreaks, resulting in high mortality rates and significant economic losses for the poultry market. As a result, there is a high demand for virology services that can promptly detect and identify viral diseases, allowing for timely and effective management actions.

Poultry Diagnostics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Geography, the poultry diagnostics market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate the market during the forecasted period. The region has cutting-edge agricultural and animal health technologies, as well as a strong R&D infrastructure. This technological advantage allows for the early detection and successful management of poultry diseases. In addition, North America, particularly the United States, has strict rules and standards for animal health and food safety. These laws require regular and comprehensive disease monitoring and testing, which increases the demand for diagnostic services.

Key Players

• The "Poultry Diagnostics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Idexx Laboratories, Zoetis, Thermo Fisher Scientific Inc., GD Animal Health, Agrobiotek Internacional, Biochek, Bionote Inc., Boehringer Ingelheim GmbH, IDvet, AffiniTech, Sanoofi, Aquila Diagnostic Systems, Clementia Biotech and HYGIENEtech Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Poultry Diagnostics Market Recent Developments
• In July 2022, BIONOTE collaborated with PSIvet, a veterinary purchasing cooperative, to make their Vcheck V200 analyzer and assays more available to veterinary practitioners in the United States.
• In August 2021, INDICAL BIOSCIENCE GmbH acquired Check-Points, a Dutch R&D firm, to broaden its poultry diagnostics product portfolio and direct-to-producer offers.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL POULTRY DIAGNOSTICS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL POULTRY DIAGNOSTICS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL POULTRY DIAGNOSTICS MARKET, BY DISEASE TYPE

• 5.1 Overview
• 5.2 Avian Salmonellosis
• 5.3 Avian Influenza
• 5.4 Newcastle Disease
• 5.5 Avian Mycoplasmosis
• 5.6 Infectious Bronchitis
• 5.7 Infectious Bursal Disease
• 5.8 Avian Pasteurellosis
• 5.9 Avian Encephalomyelitis
• 5.10 Avian Reovirus
• 5.11 Chicken Anemia

6 GLOBAL POULTRY DIAGNOSTICS MARKET, BY SERVICES

• 6.1 Overview
• 6.2 Virology
• 6.3 Bacteriology
• 6.4 Parasitology

7 GLOBAL POULTRY DIAGNOSTICS MARKET, BY TEST TYPE

• 7.1 Overview
• 7.2 Enzyme-Linked Immunosorbent Assay (Elisa) Tests
• 7.3 Polymerase Chain Reaction (PCR) Tests
• 7.4 Other Diagnostic Tests

8 GLOBAL POULTRY DIAGNOSTICS MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
• 8.6 Rest of the World
  • 8.6.1 Middle East And Africa

9 GLOBAL POULTRY DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Share
• 9.3 Vendor Landscape
• 9.4 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Idexx Laboratories, Inc.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Zoetis, Inc.
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Thermo Fisher Scientific Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Qiagen N.V.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 GD Animal Health
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 IDVet
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Affinitech, Ltd.
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Agrobiotek Internacional
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Biochek
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Bionote, Inc.
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments
• 10.11 Boehringer Ingelheim GmbH
  • 10.11.1 Overview
  • 10.11.2 Financial Performance
  • 10.11.3 Product Outlook
  • 10.11.4 Key Developments
• 10.12 Bioingentech Biotechnologies, Inc.
  • 10.12.1 Overview
  • 10.12.2 Financial Performance
  • 10.12.3 Product Outlook
  • 10.12.4 Key Developments
• 10.13 Megacor Diagnostik GmbH
  • 10.13.1 Overview
  • 10.13.2 Financial Performance
  • 10.13.3 Product Outlook
  • 10.13.4 Key Developments

11 Appendix

• 11.1 Related Reports